MALISS

1 paper1 finding

Humans1

Associations

1

Progression-free survival

downin silico1

1 study

MALISS predicts progression-free survival in silico.
“The MALISS signature effectively stratified patients into high- and low-risk groups with distinct progression-free survival.”
In silicostage II/III colorectal cancer
Unveiling tumor senescence-driven prognostic heterogeneity via MALISS in stage II/III colorectal cancer
Frontiers in immunology6 Jan 2026

Latest

1 in 12 months

Frontiers in Immunology22 Jan

Unveiling tumor senescence-driven prognostic heterogeneity via MALISS in stage II/III colorectal cancer

Cohort study of 1,296 peopleColorectal cancer